{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:08:56Z","timestamp":1792649336991,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"DOI":"10.1007\/s11606-026-10296-8","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:02:54Z","timestamp":1772478174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hospitalist Buprenorphine Prescribing Before and After X-Waiver Removal at an Academic Center"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3550-2057","authenticated-orcid":false,"given":"Rashmi","family":"Bharadwaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Mangino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Troy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fanucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"South","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"10296_CR1","unstructured":"Agency for Healthcare Research and Quality (AHRQ), Healthcare Cost and Utilization Project (HCUP), State Inpatient Databases (SID). 2010\u20132021 and quarterly data for 2022. Accessed 18 Oct 2022."},{"key":"10296_CR2","doi-asserted-by":"crossref","unstructured":"Siddiqi K, Freeman PR, Fanucchi LC, Slavova S. Rural-urban differences in hospitalizations for opioid use-associated infective endocarditis in Kentucky, 2016\u20132019. J Rural Health. 2022;38(3).","DOI":"10.1111\/jrh.12605"},{"key":"10296_CR3","doi-asserted-by":"publisher","unstructured":"Hedegaard H, Minino A, Spencer M, Warner M. Drug overdose deaths in the United States, 1999\u20132020. NCHS Data Brief. 2021;(428). https:\/\/doi.org\/10.15620\/cdc:112340.","DOI":"10.15620\/cdc:112340"},{"key":"10296_CR4","unstructured":"National Institute on Drug Abuse (NIDA). Drug overdose deaths: Facts and figures. Updated August 21, 2024. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates. Accessed 26 Aug 2024."},{"key":"10296_CR5","doi-asserted-by":"crossref","first-page":"100120","DOI":"10.1016\/j.dadr.2022.100120","volume":"5","author":"BP O\u2019Rourke","year":"2022","unstructured":"O\u2019Rourke BP, Hogan TH, Teater J, et al. Initiation of medication for opioid use disorder across a health system: A retrospective analysis of patient characteristics and inpatient outcomes. Drug Alcohol Depend Rep. 2022;5:100120.","journal-title":"Drug Alcohol Depend Rep."},{"key":"10296_CR6","unstructured":"Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63. PEP20\u201302\u201301\u2013006. Published 2020. Accessed June 18, 2023."},{"issue":"9","key":"10296_CR7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jhm.12893","volume":"17","author":"SL Calcaterra","year":"2022","unstructured":"Calcaterra SL, Martin M, Bottner R, et al. Management of opioid use disorder and associated conditions among hospitalized adults: A consensus statement from the Society of Hospital Medicine. J Hosp Med. 2022;17(9):744-756.","journal-title":"J Hosp Med."},{"key":"10296_CR8","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.dadr.2023.100164","volume":"7","author":"A Silwal","year":"2023","unstructured":"Silwal A, Talbert J, Bohler RM, et al. State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements. Drug Alcohol Depend Rep. 2023;7:100164.","journal-title":"Drug Alcohol Depend Rep."},{"key":"10296_CR9","unstructured":"Kentucky General Assembly. Title 201 Chapter 9 Regulation 270. Kentucky Administrative Regulations. https:\/\/apps.legislature.ky.gov\/law\/kar\/titles\/201\/009\/270\/. Accessed 20 Jun 2023."},{"issue":"10","key":"10296_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.12788\/jhm.3352","volume":"15","author":"J Berk","year":"2020","unstructured":"Berk J, Rogers KM, Wilson DJ, Thakrar A, Feldman L. Missed Opportunities for Treatment of Opioid Use Disorder in the Hospital Setting: Updating an Outdated Policy. J Hosp Med. 2020;15(10):619-621.","journal-title":"J Hosp Med."},{"key":"10296_CR11","doi-asserted-by":"publisher","first-page":"100106","DOI":"10.1016\/j.dadr.2022.100106","volume":"5","author":"MK Reed","year":"2022","unstructured":"Reed MK, Murali V, Sarpoulaki N, Zavodnick JH, Hom JK, Rising KL. Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder. Drug Alcohol Depend Rep. 2022;5:100106.","journal-title":"Drug Alcohol Depend Rep."},{"key":"10296_CR12","unstructured":"Congress. Consolidated Appropriations Act, 2023. 2022. https:\/\/www.congress.gov\/117\/bills\/hr2617\/BILLS-117hr2617enr.pdf."},{"key":"10296_CR13","unstructured":"Substance Abuse and Mental Health Services Administration. Waiver elimination (MAT Act). January 10, 2023. https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/waiver-elimination-mat-act. Accessed 9 Jul 2023."},{"key":"10296_CR14","doi-asserted-by":"publisher","first-page":"104381","DOI":"10.1016\/j.drugpo.2024.104381","volume":"126","author":"PJ Roy","year":"2024","unstructured":"Roy PJ, Suda K, Luo J, et al. Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis. Int J Drug Policy. 2024;126:104381.","journal-title":"Int J Drug Policy."},{"issue":"20","key":"10296_CR15","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1001\/jama.2023.5038","volume":"329","author":"Q Luo","year":"2023","unstructured":"Luo Q, Erikson CE. Changes in waivered clinicians prescribing buprenorphine and prescription volume by patient limit. JAMA. 2023;329(20):1792-1794.","journal-title":"JAMA."},{"issue":"16","key":"10296_CR16","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1056\/NEJMc2312906","volume":"390","author":"KP Chua","year":"2024","unstructured":"Chua KP, Bicket MC, Bohnert ASB, Conti RM, Lagisetty P, Nguyen TD. Buprenorphine dispensing after elimination of the waiver requirement. N Engl J Med. 2024;390(16):1530-1532.","journal-title":"N Engl J Med."},{"key":"10296_CR17","doi-asserted-by":"publisher","unstructured":"Guy GP Jr, Jones CM, Rikard SM, Zhang K, Olsen Y. Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing.\u00a0J Gen Intern Med. Published online June 25, 2025. https:\/\/doi.org\/10.1007\/s11606-025-09655-8","DOI":"10.1007\/s11606-025-09655-8"},{"key":"10296_CR18","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Erlbaum; 1988."},{"issue":"6","key":"10296_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.4097\/kjae.2016.69.6.555","volume":"69","author":"DK Lee","year":"2016","unstructured":"Lee DK. Alternatives to P value: confidence interval and effect size. Korean J Anesthesiol. 2016;69(6):555-562.","journal-title":"Korean J Anesthesiol."},{"key":"10296_CR20","doi-asserted-by":"publisher","first-page":"108627","DOI":"10.1016\/j.drugalcdep.2021.108627","volume":"221","author":"EM Stone","year":"2021","unstructured":"Stone EM, Kennedy-Hendricks A, Barry CL, Bachhuber MA, McGinty EE. The role of stigma in U.S. primary care physicians\u2019 treatment of opioid use disorder. Drug Alcohol Depend. 2021;221:108627.","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10296_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08897077.2020.1748169","volume":"43","author":"S Calcaterra","year":"2022","unstructured":"Calcaterra S, Binswanger I, Edelman EJ, McNair B, Wakeman S, O'Connor P. The impact of access to addiction specialists on attitudes, beliefs, and hospital-based opioid use disorder-related care: A survey of hospitalist physicians. Subst Abus. 2022;43(1):143-151.","journal-title":"Subst Abus."},{"issue":"3","key":"10296_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.12788\/jhm.3311","volume":"15","author":"H Englander","year":"2020","unstructured":"Englander H, Priest KC, Snyder H, Martin M, Calcaterra S, Gregg J. A call to action: Hospitalists\u2019 role in addressing substance use disorder. J Hosp Med. 2020;15(3):184-187.","journal-title":"J Hosp Med."},{"key":"10296_CR23","doi-asserted-by":"crossref","unstructured":"Shah, Rushabh et al. \u201cUtility of an Integrated Health System Specialty Pharmacy in Provision of Extended-Release Buprenorphine for Patients with Opioid Use Disorder.\u201d\u00a0American journal of health-system pharmacy\u00a080.1 (2025): e59\u2013e66. Print.","DOI":"10.1093\/ajhp\/zxac269"},{"key":"10296_CR24","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMp2301479","volume":"388","author":"S Wakeman","year":"2023","unstructured":"Wakeman S, Beletsky L. Beyond the X\u2014Next steps in policy reforms to address the overdose crisis. N Engl J Med. 2023;388:1639-1641.","journal-title":"N Engl J Med."},{"key":"10296_CR25","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMp2204687","volume":"387","author":"H Englander","year":"2022","unstructured":"Englander H, Davis C. Hospital standards of care for people with substance use disorder. N Engl J Med. 2022;387:672-675.","journal-title":"N Engl J Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10296-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:02:57Z","timestamp":1772478177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10296-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":25,"alternative-id":["10296"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10296-8","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Kentucky Institutional Review Board (IRB) assessed and approved this study (Protocol Number: 79396). The study does not include any human data or tissue, so consent to publish is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}